key: cord-0284112-bzbhe4ht
authors: Dhillon, Arun; Deme, Justin C.; Furlong, Emily; Roem, Dorina; Jongerius, Ilse; Johnson, Steven; Lea, Susan M.
title: Molecular basis for B. pertussis interference with complement, coagulation, fibrinolytic and contact activation systems: The cryo-EM structure of the Vag8-C1 inhibitor complex
date: 2020-10-06
journal: bioRxiv
DOI: 10.1101/2020.10.05.327577
sha: 12cf3e3202d5b8094d8a57936cd0e8f09153b32b
doc_id: 284112
cord_uid: bzbhe4ht

Complement, contact activation, coagulation, and fibrinolysis are serum protein cascades that need strict regulation to maintain human health. Serum glycoprotein, C1-inhibitor (C1-INH) is a key regulator (inhibitor) of serine proteases of all the above-mentioned pathways. Recently, an autotransporter protein, Virulence Associated Gene 8 (Vag8) produced by the whopping cough causing pathogen, Bordetella pertussis has been shown to bind and interfere with C1-INH function. Here we present the structure of Vag8: C1-INH complex determined using cryo-electron microscopy at 3.6 Å resolution. The structure shows a unique mechanism of C1-INH inhibition not employed by other pathogens where Vag8 sequesters the Reactive Centre Loop of the C1-INH preventing its interaction with the target proteases. Importance The structure 105 kDa protein complex is one of the smallest to be determined using cryo-electron microscopy at high resolution. The mechanism of disrupting C1-INH revealed by the structure is crucial to understand how pathogens by producing a single virulence factor can disturb several homeostasis pathways. Virulence mechanisms such as the one described here assume more importance given the emerging evidence about dysregulation of contact activation, coagulation and fibrinolysis leading to COVID-19 pneumonia.

To that end, we have determined the structure of the Vag8 passenger domain in complex 97 with the C1-INH Serpin domain using single particle cryo-electron (cryo-EM) microscopy to complement regulatory control by a unique mechanism not previously seen in other pathogens. 102 Sequestration of C1-INH in this manner not only leads to complement evasion but also 103 promotes kallikrein activation, leading to increased levels of the vasoactive bradykinin, 104 increased fibrinolysis, and coagulation. Thus B. pertussis widely perturbs serum activities 105 across a broad spectrum by production of a single protein molecule. Table 1 ), mutation of multiple residues within the cleft to alanine was required to prevent 181 formation of the complex emphasising the extended nature of the interaction site (Figures 2,   182 3). 

Complement and its role in innate and adaptive

Isolation of tissue-type plasminogen activator-inhibitor 339 complexes from human plasmaEvidence for a rapid plasminogen activator inhibitor

The inhibition of plasmin, plasma 342 kallikrein, plasma permeability factor, and the C'1r subcomponent of the first 343 component of complement by serum C'1 esterase inhibitor

Pertussis: Microbiology, Cytokine Storm; What We Know So Far

The contact activation system as a potential 417 therapeutic target in patients with COVID-19

Single-particle cryo-EM-Improved 419 ab initio 3D reconstruction with SIMPLE/PRIME

Estimation of high-order aberrations and 421 anisotropic magnification from cryo-EM data sets in RELION -3.1

How low can we go? Structure determination of small 423 biological complexes using single-particle cryo-EM

Features and development of Coot

Pannu 427 NS. 2016. How Dextran Sulfate Affects C1-inhibitor Activity: A Model for 428

Real-space refinement in PHENIX for cryo-EM and crystallography

Temesszentandrási G, Cervenak L, Gál P, Dobó J, de Maat S, Maas C, Farkas H, Varga